Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers

ClinicalTrials.gov ID: NCT00000879

Public ClinicalTrials.gov record NCT00000879. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 9:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I/II Study to Evaluate the Safety and Immunogenicity of ALVAC HIV Vaccines Alone and With AIDSVAX B/B in Children Born to HIV-Infected Mothers

Study identification

NCT ID
NCT00000879
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
48 participants

Conditions and interventions

Interventions

  • ALVAC(2)120(B,MN)GNP (vCP1452) Biological
  • MN rgp120/HIV-1 and GNE8 rgp120/HIV-1 Biological
  • ALVAC-HIV MN120TMG (vCP205) Biological

Biological

Eligibility (public fields only)

Age range
0 Days to 3 Days
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Mar 31, 2005
Last update posted
Oct 28, 2021

Ends 2005

United States locations

U.S. sites
17
U.S. states
8
U.S. cities
14
Facility City State ZIP Site status
Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach California 90801
Children's Hosp. of Orange County Orange California 92868
UCSF Pediatric AIDS CRS San Francisco California
Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases Torrance California
Mt. Sinai Hosp. Med. Ctr. - Chicago, Womens & Childrens HIV Program Chicago Illinois 60608
Chicago Children's CRS Chicago Illinois
Tulane Univ. Health Science Ctr., Tulane Univ. Hosp. & Clinic New Orleans Louisiana
Univ. of Maryland Med. Ctr., Div. of Ped. Immunology & Rheumatology Baltimore Maryland 21201
HMS - Children's Hosp. Boston, Div. of Infectious Diseases Boston Massachusetts
WNE Maternal Pediatric Adolescent AIDS CRS Worcester Massachusetts
Nyu Ny Nichd Crs New York New York 10016
Columbia IMPAACT CRS New York New York 10032
SUNY Upstate Med. Univ., Dept. of Peds. Syracuse New York 13210
Jacobi Med. Ctr. Bronx NICHD CRS The Bronx New York 10461
Univ. of Pennsylvania Health System, Hosp. of the Univ. of Pennsylvania Philadelphia Pennsylvania 19104
The Children's Hosp. of Philadelphia IMPAACT CRS Philadelphia Pennsylvania
Seattle Children's Hospital CRS Seattle Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000879, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 28, 2021 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00000879 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →